High-protein shakes lead product type at 37.4% in 2026 with GLP-1 pharmacotherapy at 40.5% by context and RTD at 47.1% by form. Adoption depends on dense nutrition that fits lower appetite but gastrointestinal tolerance and household cost can limit repeat use.
Post Weight Loss Muscle Recovery Nutrition Market Analysis By End UserPost Weight Loss Muscle Recovery Nutrition Market Analysis By Product FormPost Weight Loss Muscle Recovery Nutrition Market Analysis By Sales ChannelPost Weight Loss Muscle Recovery Nutrition Market Analysis By Weight Loss ContextPost Weight Loss Muscle Recovery Nutrition Market Opportunity Matrix Growth Vs ValuePost Weight Loss Muscle Recovery Nutrition Market Breakdown By Product Type, Weight Loss Context, And Region